Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...

The approved strengths for the said drug are 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg. Diltiazem Hydrochloride Extended-Release (ER) capsules are indicated for the treatment of hypertension.

Alembic Pharmaceuticals Limited received final approval from the USFDA for Diltiazem Hydrochloride Extended-Release Capsules USP. The approved strengths include 120 mg, 180 mg, and 240 mg.

Refer label for a detailed indication. Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg have an estimated market size of US$ 28.2 million for twelve months ending ...

Mumbai: Drug maker Alembic Pharmaceuticals Ltd has recently announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the abbreviated new drug ...

IPC Indice de Precios Y Cotizaciones 50,759.51-337.13-0.66% ...

This article is provided for informational purposes and does not constitute investment advice. You could lose all of your capital. Looking to invest in the best micro-cap cryptocurrencies with strong ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Commissions do not affect our editors' opinions or evaluations. Small-cap stocks offer big advantages for your investment portfolio. Nimble, small companies grow faster than large-cap firms ...

On Nov. 11, Bitcoin (BTC) reached a market capitalization of $1.62 trillion amid the ongoing bull market, concurrently bringing up the global crypto market cap to its former glory of $2.71 ...

But in between are “Goldilocks”—mid-cap stocks. Those companies are neither too small to be at risk of folding due to one misstep, nor so large that their biggest, fastest growth is well ...